Skip to main content

Hyperion Defi, Inc.

HYPD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001682639

No open-market purchases or sales by Hyperion Defi, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Hyperion Defi, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of HYPD: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders61150−10
Shares11.8M124.8K13.4M+1.72M (+14.7%)
Value$7.01M$74.1K$6.91M−$21.2K (−0.3%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held Hyperion Defi, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to HYPD in Q3 2024
InstitutionSharesValue% of portfolio
Diametric Capital, LP157,966$81.6K0.04%
BlackRock, Inc.90,436$46.7K0.00%
Financial Management Network Inc81,250$39.2K0.01%
Prelude Capital Management, LLC57,527$29.7K0.00%
Two Sigma Securities, LLC44,647$23.1K0.00%
Mariner, LLC21,739$11.2K0.00%
Soltis Investment Advisors LLC18,236$9.42K0.00%

Sold out (17)

Institutions that held Hyperion Defi, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Not filed for Q3 2024 yet (1)

Institutions that held Hyperion Defi, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HYPD in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.124,799$74.1K